Brain insulin controls adipose tissue lipolysis and lipogenesis.

  • Thomas Scherer
  • James O'Hare
  • Kelly Diggs-Andrews
  • Martina Schweiger
  • Bob Cheng
  • Claudia Lindtner
  • Elizabeth Zielinski
  • Prashant Vempati
  • Kai Su
  • Shveta Dighe
  • Thomas Milsom
  • Michelle Puchowicz
  • Ludger Scheja
  • Rudolf Zechner
  • Simon J Fisher
  • Stephen F Previs
  • Christoph Buettner

Abstract

White adipose tissue (WAT) dysfunction plays a key role in the pathogenesis of type 2 diabetes (DM2). Unrestrained WAT lipolysis results in increased fatty acid release, leading to insulin resistance and lipotoxicity, while impaired de novo lipogenesis in WAT decreases the synthesis of insulin-sensitizing fatty acid species like palmitoleate. Here, we show that insulin infused into the mediobasal hypothalamus (MBH) of Sprague-Dawley rats increases WAT lipogenic protein expression, inactivates hormone-sensitive lipase (Hsl), and suppresses lipolysis. Conversely, mice that lack the neuronal insulin receptor exhibit unrestrained lipolysis and decreased de novo lipogenesis in WAT. Thus, brain and, in particular, hypothalamic insulin action play a pivotal role in WAT functionality.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer2
ISSN1550-4131
StatusVeröffentlicht - 2011
pubmed 21284985